this gives information of almost all the drugs available nowadays and its function. this website also gives information on different modern lifestyles
Monday, March 8, 2010
Bactrim
Saturday, August 1, 2009
Kanamycin( strong antibiotic)
Friday, July 10, 2009
bactocill, an antibiotic
Monday, July 6, 2009
bacteria fighter
Sunday, July 5, 2009
Topical medicine for acne
Sunday, June 28, 2009
Dalfopristin or synercid
Dalfopristin and quinupristin is a combination antibiotic that fights severe or life-threatening infection caused by bacteria.
Dalfopristin and quinupristin is used to treat severe infections in the blood and other body systems.
Dalfopristin and quinupristin may also be used for other purposes not listed in this medication guide
You should not receive this medication if you are allergic to dalfopristin and quinupristin.
Before receiving dalfopristin and quinupristin, tell your doctor if you have liver or kidney disease, or a history of any type of allergy.
Antibiotic medicines can cause diarrhea, which may be a sign of a new infection. If you have diarrhea that is watery or has blood in it, call your doctor. Do not use any medicine to stop the diarrhea unless your doctor has told you to.
Dalfopristin and quinupristin is given as an injection through a needle placed into a vein. Your doctor, nurse, or other healthcare provider will give you this injection.
Dalfopristin and quinupristin is most often given in a hospital setting. The medicine must be given slowly through an IV infusion, and can take up to 1 hour or longer to complete.
Dalfopristin and quinupristin is usually given for at least 7 days, or longer for more severe infections.
Before receiving dalfopristin and quinupristin, tell your doctor if you are using any of the following drugs:
astemizole (Hismanal), cisapride (Propulsid), or terfenadine (Seldane)
cyclosporine (Gengraf, Neoral, Sandimmune)
digoxin (digitalis, Lanoxin)
diazepam (Valium) or midazolam (Versed)
methylprednisolone (Medrol, Duralone, Medipred, and others)
cyclosporine (Gengraf, Neoral, Sandimmune), tacrolimus (Prograf)
cancer medications such as vinblastine (Velban), vincristine (Oncovin), vinorelbine (Navelbine), docetaxel (Taxotere), paclitaxel (Taxol)
a calcium channel blocker such as amlodipine (Norvasc), diltiazem (Tiazac, Cartia, Cardizem), felodipine (Plendil), nicardipine (Cardene), nifedipine (Procardia, Adalat), nimodipine (Nimotop), nisoldipine (Sular), or verapamil (Calan, Covera, Isoptin, Verelan)
HIV or AIDS medications such as delavirdine (Rescriptor), indinavir (Crixivan), nevirapine (Viramune), or ritonavir (Norvir)
heart rhythm medications such as disopyramide (Norpace), lidocaine, or quinidine (Quinaglute, Quinidex).
Saturday, June 20, 2009
Mafenide
Mafenide is an antibiotic that fights bacteria in the body.
Mafenide topical (for the skin) is used to prevent infection in severe burn wounds.
Mafenide may also be used for other purposes not listed in this medication guide.
You should not receive this medication if you are allergic to mafenide.
Before being treated with mafenide, tell your doctor if you are allergic to any drugs (especially sulfa drugs), or if you have kidney disease or glucose-6-phosphate dehydrogenase (G6PD) deficiency.
Before you are treated with mafenide topical, tell your doctor if you are pregnant or breast-feeding.
Tell your caregivers right away if you have a serious side effect such as pale or yellowed skin, dark colored urine, fever, confusion or weakness, chest pain, fast or pounding heartbeats, confusion, vomiting, appetite changes, muscle weakness, bone pain, rapid breathing, gasping, or feeling short of breath, or severe skin rash with bruising, severe tingling, numbness, or pain.
Follow your doctor's instructions about any restrictions on food, beverages, or activity while you are being treated with mafenide.
Your doctor will determine the correct amount and type of this medication to use. You will receive this medication in a hospital or burn unit setting.
Mafenide cream is usually applied to the burn wound once or twice a day. The wound should be kept covered with this medication at all times during treatment.
Mafenide powder is usually mixed together with a saline solution and applied over a gauze dressing using a syringe or irrigation tube. Mafenide is usually applied several times per day in order to keep the bandaging wet.
Usual Adult Dose for Burns - External:
Solution: Wet burn dressing with mafenide solution and cover grafted area. The dressing should be kept wet by injecting solution into irrigation tubing every 4 hours or moistening gauze dressing every 6 to 8 hours, as necessary.
Cream: Apply to cleaned and debrided burn(s) once or twice daily, at a thickness of not more than 1/16 inch. The cream should be reapplied whenever it is removed to keep burn(s) covered at all times. Thin layers of dressings may be used, if necessary. Treatment should continue until healing is progressing well or the skin is ready for grafting.
Usual Pediatric Dose for Burns - External:
Solution:
>3 months: Wet burn dressing with mafenide solution and cover grafted area. The dressing should be kept wet by injecting solution into irrigation tubing every 4 hours or moistening gauze dressing every 6 to 8 hours, as necessary.
Cream: Apply to cleaned and debrided burn(s) once or twice daily, at a thickness of not more than 1/16 inch. The cream should be reapplied whenever it is removed to keep burn(s) covered at all times. Thin layers of dressings may be used, if necessary. Treatment should continue until healing is progressing well or the skin is ready for grafting.
Friday, June 19, 2009
Dactinomycin
Dactinomycin is very toxic. Do not inhale the dust or vapors of Dactinomycin . Do not get Dactinomycin in your eyes, nose, mouth, or onto your skin. Do not come into contact with Dactinomycin if you are pregnant. Dactinomycin is given through a vein. If Dactinomycin leaks out of the vein (extravasation), severe damage to the area around the injection site will occur. Tell your doctor or health care provider immediately if you notice any discomfort, pain, or redness at the injection site.
Dactinomycin is used for:
Treating certain types of cancer. It may be used alone or with other medicines.
Dactinomycin is an antineoplastic. It works by killing certain cancer cells.
Do NOT use Dactinomycin if:
* you are allergic to any ingredient in Dactinomycin
* you have chickenpox (varicella infection), or shingles (herpes zoster infection), or if you have had either of these infections recently
Contact your doctor or health care provider right away if any of these apply to you.
Use Dactinomycin as directed by your doctor. Check the label on the medicine for exact dosing instructions.
* Dactinomycin is usually given as an injection at your doctor's office, hospital, or clinic. Ask your doctor or pharmacist any questions you may have about Dactinomycin .
* If you get Dactinomycin in your eyes or on your skin, rinse the area with water for 15 minutes. Remove any contaminated clothing and do not reuse. Contaminated shoes must be cleaned completely before reuse.
* If you miss a dose of Dactinomycin , contact your doctor right away.
Ask your health care provider any questions you may have about how to use Dactinomycin .
Dactinomycin is usually handled and stored by a health care provider. If you are using Dactinomycin at home, store Dactinomycin as directed by your pharmacist or health care provider.
Baciim
To reduce the development of drug-resistant bacteria and maintain the effectiveness of bacitracin and other antibacterial drugs, bacitracin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.
Nephrotoxicity: Bacitracin in parenteral (intramuscular) therapy may cause renal failure due to tubular and glomerular necrosis. Its use should be restricted to infants with staphylococcal pneumonia and empyema when due to organisms shown to be susceptible to bacitracin. It should be used only where adequate laboratory facilities are available and when constant supervision of the patient is possible.
Renal function should be carefully determined prior to and daily during therapy. The recommended daily dose should not be exceeded and fluid intake and urinary output maintained at proper levels to avoid kidney toxicity. If renal toxicity occurs the drug should be discontinued. The concurrent use of other nephrotoxic drugs, particularly streptomycin, kanamycin, polymyxin B, polymyxin E (colistin), neomycin, and viomycin, should be avoided.
The vial content of Bacitracin for Injection USP is sterile. The therapeutic class of the drug is antibacterial and is intended for intramuscular use. Bacitracin is an antibiotic polypeptide complex and its major component is bacitracin A which has a molecular weight of 1422.7.
Each vial contains 50,000 units of bacitracin.
Bacitracin is a white to pale buff, hygroscopic powder, odorless or having a slight odor. It is freely soluble in water; insoluble in acetone, chloroform, and ether. While soluble in alcohol, methanol, and glacial acetic acid, there is some insoluble residue. It is precipitated from its solutions and inactivated by many of the heavy metals.
Bacitracin, an antibiotic substance derived from cultures of Bacillus subtilis (Tracey), exerts pronounced antibacterial action in vitro against a variety of gram-positive and a few gram-negative organisms. However, among systemic diseases, only staphylococcal infections qualify for consideration of bacitracin therapy. Bacitracin is assayed against a standard and its activity is expressed in units, 1 mg having a potency of not less than 50 units.
Susceptibility plate testing: If the Kirby-Bauer method of disk susceptibility is used, a 10 unit bacitracin disk should give a zone of over 13mm when tested against a bacitracin-susceptible strain of Staphylococcus aureus. Absorption of bacitracin following intramuscular injection is rapid and complete. A dose of 200 or 300 units/kg every 6 hours gives serum levels of 0.2 to 2 mcg/mL in individuals with normal renal function. The drug is excreted slowly by glomerular filtration. It is widely distributed in all body organs and is demonstrable in ascitic and pleural fluids after intramuscular injection.
Patients should be counseled that antibacterial drugs including bacitracin should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When bacitracin is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by bacitracin or other antibacterial drugs in the future.
Infant dose: For infants under 2500 grams – 900 units/kg/24 hours in 2 or 3 divided doses. For infants over 2500 grams – 1,000 units/kg/24 hours, in 2 or 3 divided doses. Intramuscular injections of the solution should be given in the upper outer quadrant of the buttocks, alternating right and left and avoiding multiple injections in the same region because of the transient pain following injection.
Preparation of Solutions – Should be dissolved in sodium chloride injection containing 2 percent procaine hydrochloride. The concentration of the antibiotic in the solution should not be less than 5,000 units per mL nor more than 10,000 units per mL.
Diluents containing parabens should not be used to reconstitute bacitracin; cloudy solutions and precipitate formation have occurred.
Reconstitution of the 50,000 unit vial with 9.8 mL of diluent will result in a concentration of 5,000 units per mL.
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit.
Monday, June 15, 2009
Macrobid
Macrobid is an antibiotic that fights bacteria in the body.
Macrobid is used to treat urinary tract infections.
Macrobid may also be used for other purposes not listed in this medication guide.
Call your doctor at once if you have a serious side effect such as: feeling short of breath (even with mild exertion), fever, chills, cough, chest pain, yellowing of the skin or eyes; pale skin, unusual weakness, numbness or tingling, or diarrhea that is watery or bloody.
Avoid using antacids without your doctor's advice. Use only the specific type of antacid your doctor recommends. Antacids contain different medicines and some types can make it harder for your body to absorb Macrobid.
Take Macrobid for the full prescribed length of time. Your symptoms may improve before the infection is completely cleared. Macrobid will not treat a viral infection such as the common cold or flu. Take Macrobid with food or milk.
You should not use Macrobid if you are allergic to nitrofurantoin, or if you have:
severe kidney disease
a history of jaundice or liver problems caused by taking nitrofurantoin
if you are urinating less than usual or not at all; or
if you are in the last 2 to 4 weeks of pregnancy.
If you have certain conditions, you may need a dose adjustment or special tests to safely take this medication. Before taking Macrobid, tell your doctor if you have:
Kidney disease
Anemia
Diabetes
An electrolyte imbalance or vitamin B deficiency
Glucose-6-phosphate dehydrogenase (G6PD) deficiency; or
Any type of debilitating disease.
FDA pregnancy category B. Macrobid is not expected to be harmful to an unborn baby, unless it is used during the last 2 to 4 weeks of pregnancy. Tell your doctor if you are pregnant or plan to become pregnant during treatment. This medication passes into breast milk and may harm a nursing baby. Do not take Macrobid without telling your doctor if you are breast feeding a baby. Do not give Macrobid to a child younger than 12 years old.
Take Macrobid exactly as prescribed by your doctor. Do not take it in larger amounts or for longer than recommended. Follow the directions on your prescription label.
Take each dose with a full glass of water. Take Macrobid with food or milk. Shake the oral suspension (liquid) well before measuring a dose. To ensure that you get the correct dose, measure the suspension with a dose-measuring spoon or dropper, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.
You may mix your liquid dose with water, milk, or fruit juice to make it easier to swallow. Drink the entire mixture right away.
Take this medication for the entire length of time prescribed by your doctor. Your symptoms may get better before the infection is completely treated. Macrobid is usually given for up to 1 week after lab tests show that the infection has cleared. Macrobid will not treat a viral infection such as the common cold or flu.
To be sure this medication is not causing harmful effects, your kidney function may need to be tested. Do not miss any scheduled appointments. Macrobid can cause you to have unusual results with certain urine glucose (sugar) tests. Tell any doctor who treats you that you are using Macrobid. Store Macrobid at room temperature away from moisture, heat, and light. Do not freeze liquid nitrofurantoin medicine.

